Intramuscular Ketamine Dosing for a 51-kg Patient
For a 51-kg patient requiring intramuscular ketamine, administer 204 mg (4 mg/kg), which is the evidence-based standard dose for procedural sedation and analgesia. 1, 2, 3
Standard IM Dosing Protocol
The FDA-approved dosing range for IM ketamine is 6.5–13 mg/kg, with 9–13 mg/kg producing surgical anesthesia within 3–4 minutes. 3
For procedural sedation specifically, 4 mg/kg IM is the recommended dose, providing 100% adequacy of sedation while maintaining a favorable safety profile. 1, 2
For your 51-kg patient, this translates to 204 mg IM (51 kg × 4 mg/kg = 204 mg). 1, 2
Dose-Response Considerations
Doses of 4–5 mg/kg IM produce adequate sedation in 93–100% of patients, representing the optimal range for emergency department procedural sedation. 4
Lower doses (2–3 mg/kg) may be considered in specific circumstances (e.g., as second-line agent after other sedatives, or in high-risk patients), though they carry a 13% inadequate sedation rate compared to <7% with standard dosing. 5, 6, 4
If a second dose is needed, administer 2–4 mg/kg (102–204 mg for this patient) after 5–10 minutes if initial sedation is inadequate. 1
Critical Safety Requirements
Before administration:
- Administer an antisialagogue (atropine 0.01 mg/kg IM = 0.51 mg for this patient) prior to ketamine to reduce excessive salivation. 1, 3
During administration:
- Ensure emergency airway equipment is immediately available. 3
- Continuously monitor vital signs including oxygen saturation, heart rate, and blood pressure. 1, 2
- Maintain capnography monitoring when available. 1
Expected Timeline and Effects
- Onset of action: 3–4 minutes after IM injection when using 9–13 mg/kg for surgical anesthesia. 3
- Duration of anesthetic effect: 12–25 minutes with standard dosing. 3
- Average recovery time: approximately 85–90 minutes from administration to discharge readiness. 1, 6
Anticipated Adverse Effects
Common side effects to monitor:
- Recovery agitation occurs in 17.6% of patients (1.6% moderate-to-severe). 1, 2
- Emesis without aspiration in 6.7% of cases. 1, 2
- Laryngospasm is rare (0.9–1.4% incidence). 1
- Transient hypoxemia in 1.6–7.3% of patients, typically responsive to supplemental oxygen. 1
Contraindications to Verify
Do not administer ketamine if the patient has:
- Ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension (ketamine increases heart rate and blood pressure dose-dependently). 1, 2
- Active psychosis. 2
- Severe hepatic dysfunction. 2
- Elevated intracranial or intraocular pressure. 2
Common Pitfall to Avoid
Warning: Patients requiring supplemental ketamine doses have significantly higher intubation rates (41.2% vs. 12.5% for single-dose patients), so use additional doses judiciously and ensure airway management capability is immediately available. 7